HEAD AND NECK SQUAMOUS CELL CANCER
Clinical trials for HEAD AND NECK SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a drug duo outsmart head and neck cancer?
Disease control CompletedThis trial is testing whether combining two drugs—toripalimab, an immunotherapy, and cetuximab, a targeted therapy—can shrink tumors in people with advanced head and neck squamous cell cancer. The study includes patients whose cancer has returned or spread after initial treatment…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a pill change head and neck cancer before surgery? small study investigates.
Knowledge-focused CompletedThis study tested whether taking the drug BYL719 (Alpelisib) for 14 days before surgery could change certain biological markers in head and neck cancer tissue. Fifteen patients with resectable head and neck squamous cell cancer took the drug, and researchers compared tissue sampl…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CANCER
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC